Chemical Structure (Ofloxacin 01)
Ofloxacin Tablet, Coated
Product Images NDC 75834-201
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Ofloxacin (NDC 75834-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Nivagen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure (Ofloxacin 02)
This appears to be a chart or graph representing the mean steady-state plasma levels of Ofloxacin after 5 days of treatment. The data is shown for 19 patients who received 400mg doses of Ofloxacin, both orally and intravenously. The graph shows plasma levels in mcg/mL over time, with measurements taken at various intervals up to 25 units.*
Figure (Ofloxacin 03)
This text provides a formula to calculate the creatinine clearance, which is a measure of the kidney's ability to filter waste products. The formula takes into account the person's weight, age, and serum creatinine level. It is specifically geared towards men, and involves multiplying the weight in kilograms by a percentage based on age (140 minus age). The result is then multiplied by the serum creatinine level in milligrams per deciliter.*
Principal Display Panel (200 mg Tablet Bottle Label)
Nivagen Ofloxacin Tablets USP 200mg, NDC 75834-199-50, is a prescription medication for bacterial infections. One bottle contains 50 tablets with each tablet comprising 200mg of Ofloxacin USP. The prescribed dosage information can be found in the package insert. It is recommended to store it at a temperature range of 20°C- 25°C (68° to 77°F) and dispense in a tight light-resistant container, keeping it out of children's reach. Nivagen Pharmaceuticals, Inc. manufactures it with a license number of G/1500 in Sacramento, CA, with manufacturing help from Cadila Pharmaceuticals Ltd., of Ahmedabad, Gujarat State, India. Please note that a medication guide is attached by the pharmacist. It was last revised in December 2018.*
Principal Display Panel (300 mg Tablet Bottle Label)
The text is a description of a medication named Nivagen, specifically Ofloxacin Tablets USP, in a bottle with 50 tablets. It includes instructions to store at a controlled room temperature and with a child-resistant closure, and a warning to keep it away from children. The usual dosage is not mentioned so the package insert must be consulted. The medication is manufactured by Cadila Pharmaceuticals Ltd in Gujarat State, India and is licensed to Nivagen Pharmaceuticals Inc. Pharmacist are required to dispense the medication with an attached medication guide. This text was issued in December 2018.*
Principal Display Panel (400 mg Tablet Bottle Label)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
